top of page
Search


EPKINLY 2026: The Newest FDA-Approved Off-the-Shelf Therapy for Relapsed B-Cell Cancers
Your diffuse large B-cell lymphoma came back after chemotherapy. Now your oncologist is talking about third-line options
Ganesh Akunoori
Sep 2412 min read
Â
Â
Â


2026 FDA-Approved Therapies for Relapsed B-Cell Cancers: A Ground-Level Guide for Patients Who Have Failed Standard Treatment
You went through the brutal opening round of chemotherapy for lymphoma or the long grind of targeted pills for CLL, and it worked. Until it did not.
Ganesh Akunoori
Sep 1610 min read
Â
Â
Â
bottom of page
